Convatec Group PLC (CTEC)
Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
220.40p
Buy
220.60p
0.40p (+0.18%)
Prices updated at 02 Apr 2026, 17:15 BST
| Prices minimum 15 mins delay
Prices in GBX
ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and infusion devices.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 2,289m | 2,439m | |
| 1,284m | 1,371m | |
| 332m | 386m | |
| 14.50 | 15.83 | |
| 191m | 175m | |
| 541m | 516m | |
| Sales, General and administrative | 840m | 874m |
| Interest expenses | 74m | 62m |
| Provision for income taxes | 55m | 55m |
| Operating expenses | 952m | 985m |
| Income before taxes | 246m | 230m |
| Net income available to common shareholders | 191m | 175m |
| 0.093 | 0.086 | |
| Net interest income | -78m | -68m |
| Advertising and promotion | - | - |
| Net investment income, net | -18m | 32m |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 0.093 | 0.086 |
| Free cash flow per share | 0.0998 | 0.1219 |
| Book value/share | 0.6451 | 0.6882 |
| Debt equity ratio | 0.698638 | 0.982872 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 793m | 940m |
| Current liabilities | 512m | 616m |
| Total capital | 2,812m | 2,916m |
| Total debt | 1,202m | 1,518m |
| Total equity | 1,689m | 1,518m |
| Total non current liabilities | - | - |
| Loans | 1,123m | 1,398m |
| Total assets | 3,515m | 3,781m |
| Total liabilities | - | - |
| Cash and cash equivalents | 65m | 68m |
| Common stock | 2,044m | 1,954m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 98m | 65m |
| Cash dividends paid | -130m | -140m |
| 274m | 285m | |
| Investments (gains) losses | -161m | -208m |
| 65m | 68m | |
| Net income | - | - |
| 396m | 470m | |
| -122m | -185m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.